Hivid and Laboratory test abnormal - a phase IV clinical study of FDA data

Summary:

Laboratory test abnormal is reported as a side effect among people who take Hivid (zalcitabine), especially for people who are 50-59 old, have been taking the drug for 2 - 5 years also take Invirase, and have Hiv infection.

The phase IV clinical study analyzes which people have Laboratory test abnormal when taking Hivid. It is created by eHealthMe based on reports of 518 people who have side effects when taking Hivid from the FDA, and is updated regularly.

What is Hivid?

Hivid has active ingredients of zalcitabine. eHealthMe is studying from 518 Hivid users. Check the latest studies of Hivid.

What is Laboratory test abnormal?

Laboratory test abnormal is found to be associated with 1,185 drugs and 1,590 conditions by eHealthMe. Check the latest studies of Laboratory test abnormal.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

518 people reported to have side effects when taking Hivid.
Among them, 18 people (3.47%) have Laboratory test abnormal.

Could Hivid cause Laboratory test abnormal?

Among these 18 people:

How long have people been on Hivid when they have Laboratory test abnormal? *

What is the age of people who have Laboratory test abnormal when taking Hivid? *

What are other drugs people take besides Hivid? *

What are other side effects people have besides Laboratory test abnormal? *

Urination - Painful: 18 people, 100.00%
Multiple-Drug Resistance: 18 people, 100.00%
Hiv Infection: 18 people, 100.00%
Immunodeficiency: 18 people, 100.00%
Kaposi's Sarcoma (a tumour caused by human herpes virus): 18 people, 100.00%
Urinary Tract Infection: 18 people, 100.00%
Lymphoedema (localized fluid retention and tissue swelling): 18 people, 100.00%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 18 people, 100.00%
Rashes (redness): 18 people, 100.00%
Drug Ineffective: 17 people, 94.44%

What are the existing conditions these people have? *

Kaposi's Sarcoma (a tumour caused by human herpes virus): 18 people, 100.00%
Hiv Infection: 18 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Hivid and have Laboratory test abnormal?

- Check whether Laboratory test abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Hivid:

Hivid (518 reports)

Browse all side effects of Hivid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Laboratory test abnormal:

Laboratory test abnormal (1,185 drugs)

Browse all the conditions that are associated with Laboratory test abnormal:

Laboratory test abnormal (1,590 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on zalcitabine (the active ingredients of Hivid) and Hivid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.